A Randomized Single Blind Safety and Efficacy Study of TOL-463 Vaginal Gel or Insert in the Treatment of Vaginitis (BV and/or VVC)
This is a Phase II study designed to assess the safety and efficacy of an investigational product, TOL-463, to treat vaginitis.
100 Clinical Results associated with Toltec Pharmaceuticals LLC
0 Patents (Medical) associated with Toltec Pharmaceuticals LLC
100 Deals associated with Toltec Pharmaceuticals LLC
100 Translational Medicine associated with Toltec Pharmaceuticals LLC